KT2

General Information


DRACP ID  DRACP00869

Peptide Name   KT2

Sequence  NGVQPKYKWWKWWKKWW

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  AMP

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HCT 116 Colon carcinoma Carcinoma IC50=50 µM MTT assay 24h 1
A431 Skin squamous cell carcinoma Carcinoma 34% Cytotoxicity=10 µM MTT assay 24h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma Not active up to 10 µM MTT assay 24h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  KT2 interacts with the plasma membrane and is then internalized into cells. Moreover, the KT2 peptide increases membrane permeability and induces cytotoxicity against cancer cells through DNA condensation, the increase of apoptotic factor protein levels, and autophagy suppression.

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00869

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Cys2<--->Gly11

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C126H164N30O21

Absent amino acids  ACDEFHILMRST

Common amino acids  W

Mass  272044

Pl  11.02

Basic residues  5

Acidic residues  0

Hydrophobic residues  7

Net charge  5

Boman Index  -2111

Hydrophobicity  -182.35

Aliphatic Index  17.06

Half Life 
  Mammalian: 2.8 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  34490

Absorbance 280nm  2155.63

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31073999

Title  The cationic cell-penetrating KT2 peptide promotes cell membrane defects and apoptosis with autophagy inhibition in human HCT 116 colon cancer cells

Doi 10.1002/jcp.28774

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.